2019
DOI: 10.1016/j.ejmech.2019.111650
|View full text |Cite
|
Sign up to set email alerts
|

Polygala tenuifolia-Acori tatarinowii herbal pair as an inspiration for substituted cinnamic α-asaronol esters: Design, synthesis, anticonvulsant activity, and inhibition of lactate dehydrogenase study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 73 publications
0
16
0
Order By: Relevance
“…The fact that α-asarone can be metabolized into α-asaronol was confirmed by liver microsomes of different species and human cytochrome P450 enzymes in other studies. , Our recent study revealed that α-asaronol, against the maximal electroshock seizure (MES), subcutaneous injection pentylenetetrazole (PTZ)-induced seizure, and 3-mercaptopropionic acid (3-MP)-induced seizure, displayed a broad spectrum of antiepileptic activity, better neuroprotective effects, and lower acute toxicity than its metabolic parent compound α-asarone . α-Asaronol and its analogues, when compared with clinical drugs such as stiripentol, lacosamide, carbamazepine, and valproic acid, possessed excellent anticonvulsant activities as well as low neurotoxicity for developing into antiepileptic drugs, especially for the treatment of refractory epilepsies . These encouraging results prompted us to develop further α-asaronol into an efficient and safe antiepileptic drug as a substitute for α-asarone.…”
Section: Introductionmentioning
confidence: 74%
“…The fact that α-asarone can be metabolized into α-asaronol was confirmed by liver microsomes of different species and human cytochrome P450 enzymes in other studies. , Our recent study revealed that α-asaronol, against the maximal electroshock seizure (MES), subcutaneous injection pentylenetetrazole (PTZ)-induced seizure, and 3-mercaptopropionic acid (3-MP)-induced seizure, displayed a broad spectrum of antiepileptic activity, better neuroprotective effects, and lower acute toxicity than its metabolic parent compound α-asarone . α-Asaronol and its analogues, when compared with clinical drugs such as stiripentol, lacosamide, carbamazepine, and valproic acid, possessed excellent anticonvulsant activities as well as low neurotoxicity for developing into antiepileptic drugs, especially for the treatment of refractory epilepsies . These encouraging results prompted us to develop further α-asaronol into an efficient and safe antiepileptic drug as a substitute for α-asarone.…”
Section: Introductionmentioning
confidence: 74%
“…Although studies have revealed that α-asarone exhibits neuroprotective effects on epilepsy ( Pages et al, 2010 ; Huang et al, 2013 ), Alzheimer’s disease ( Chen et al, 2020 ), and stroke ( Lee et al, 2018 ), the nonnegligible side effects of its carcinogenic and genotoxic potential limit its application ( Chamorro et al, 1993 ; Marczewska et al, 2013 ). With the synthesis of α-asaronol in our lab ( Bai et al, 2019 ), its pharmacokinetics ( Sun et al, 2019 ) and biological activities were gradually evaluated, such as antioxidative stress ( He et al, 2018 ), alleviating neurotoxicity, and anticonvulsant ( Jin et al, 2020 ) and anti-epilepsy by balancing neurotransmitters (data unpublished). However, the effect of α-asaronol on myelination in PWMI neonatal rats and the underlying mechanisms remain elusive.…”
Section: Introductionmentioning
confidence: 99%
“…At present, the major choice for the treatment of epilepsy in the clinic is still mainly drugs (He et al 2018). However, the existing clinical antiepileptic drugs (AEDs) are only about 2/3 of epileptic patients achieve a satisfactory seizure control, and the treatment effect is poor or ineffective for the other 1/3 of epileptic patients (He et al 2018; Kondrat-Wróbel and Łuszczki, 2018; Bai et al 2019). Currently available antiepileptic drugs can also not prevent the development of epilepsy drug resistance, which is considered to be a challenge in epilepsy treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Traditional Chinese medicine has a long history in the treatment of epilepsy, which was recorded in the classical masterpieces Inner Canon of Huangdi ( ) as early as 2200 years ago. In particular, these records revealed the national characteristics and unique advantages of traditional Chinese herbs in the treatment and control seizure in children (Bai et al 2019…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation